News

We're hiring: Communication Coordinator for LifeSciences@Work

Are you passionate about science communication and eager to help innovative life sciences startups grow their impact? LifeSciences@Work is looking for a Communication Coordinator to strengthen our team.
We're hiring: Communication Coordinator for LifeSciences@Work

TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001

Utrecht, the Netherlands, June 24, 2026 – TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, today announced the second and final closing of its Ser
TargED Secures €40.4M Series A Extension

Cohort 2 BioVenture Builder: Selection process started

Many early‑stage biotech founders get stuck between preclinical validation and investor readiness.
Cohort 2 BioVenture Builder: Selection process started

Rotterdam Square launches NL USA Health Accelerator in collaboration with Cedars-Sinai Accelerator+ and Erasmus MC

Rotterdam Square is pleased to announce the launch of the NL USA Health Accelerator, a new international initiative developed in collaboration with Cedars-Sinai Accelerator+ and Erasmus MC, to be unveiled at the leading healthcare innovation event, HLTH Europe.
The people behind the NL USA Health Accelerator Program pose for a group photo

Lumox wins Health & Wellbeing category at the NL Startup Competition

Lumox, alumnus of the Venture Challenge, has been named the winner of the Health & Wellbeing category at the NL Startup Competition 2026.
Lumox

These are the Venture Challenge Spring 2026 teams!

Six teams have started the Venture Challenge Spring edition 2026! These starting life sciences entrepreneurs will learn everything about building and pitching a business plan.
Spring 2026

Venture Challenge alumnus BIMINI Biotech secures €2.2M Eurostars funding

BIMINI Biotech, alumnus of the Venture Challenge Fall 2019, has secured €2.2 million in Eurostars funding for the MYELO-WASP project, aimed at developing a new class of targeted therapies for leukemia.
https://www.linkedin.com/posts/mauritsvandennieuwboer_excited-to-share-we-secured-22m-eurostars-share-7454757593341902849-SCiE?utm_source=share&utm_medium=member_desktop&rcm=ACoAAC5oynoBUAn3wLyUzxN-synau9ZuiYrIpKk

From bar idea to award-winning healthcare innovation: the journey of Momo Medical

On March 27, 2026, the story of Dutch healthtech company Momo Medical was highlighted as an example of how perseverance and a shift in mindset can turn a promising idea into a successful healthcare innovation.
From bar idea to award-winning healthcare innovation: the journey of Momo Medical

Daranamix wins Proefdiervrij Venture Challenge 2026

On April 24, during the annual Proefdiervrij Event at CORPUS in Leiden, Daranamix was announced as the winner of the Proefdiervrij Venture Challenge 2026.
 Daranamix wins Proefdiervrij Venture Challenge 2026

Venture Challenge alumni advance to final phase of Academic Startup Competition 2026

Four Venture Challenge alumni have been selected among the top 10 startups advancing to the final phase of the Academic Startup Competition 2026 (ASC26).
Four Venture Challenge alumni have been selected among the top 10 startups advancing to the final phase of the Academic Startup Competition 2026 (ASC26).  The selected teams are: • Twente Medical Optics (Venture Challenge Spring 2024) • Constellate Proteomics (Venture Challenge Fall 2025) • Myriagon (Venture Challenge Fall 2025 winner) • UCANACT (Venture Challenge 2025/2026 MedTech edition)  Following an intense Pitch Day, these startups stood out for their strong scientific foundation, clear vision, and ab